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Why care about Occult Afib in Cryptogenic 
Stroke?
▪ Afib has 5x risk of 
stroke
▪ Found in up to 1/3rd of 
cryptogenic strokes
▪ Specific treatments for 
Afib
How do we Classify Stroke Types?
▪ TOAST Classification Scheme 
▪ Large Vessel Disease
– Carotid stenosis >50%, intracranial atherosclerosis >50% in a supplying vessel 
to the ischemic territory
▪ Small Vessel Disease
– Lacunar infarcts: pons, midbrain, thalamus, basal ganglia and periventricular or 
subcortical white matter
▪ Cardioembolic
– Atrial Fibrillation, LV thrombus, Cardiomyopathy-Low EF <35%, endocarditis
▪ Other Determined Causes
– Dissection, Vasculitis, Hypercoagable states etc…
▪ Cryptogenic and ESUS
– Occult PAF, undetected PFO, cardiac structural defect, hypercoagulable 
condition etc
Determining Stroke Type
▪ Standard Stroke Work-Up
– Adequate brain imaging (MRI or repeat CT)
– Vascular imaging of cervical and cerebral vessels 
(MRA, CTA, CD+TCD or C.Angio)
– 12 Lead EKG and Telemetry during IPD stay
– Echocardiography with bubble (TTE)
– Screening labs for Plts, Coags, Lipids and HgA1C
▪ If no cause is found, and the “cryptogenic infarct is 
non-lacunar and appears to be “embolic”, you may 
consider the infarction to be “ESUS”
Embolic Stroke of Undetermined Source:
Treatment?
▪ “That sounds like a lot to have to work up!”
Can’t we just treat all cryptogenic strokes the 
same?
Why not anticoagulate them?
Embolic Stroke of Undetermined Source:
Treatment – Anticoagulation?
▪ Warfarin - Aspirin Recurrent Stroke Study (WARSS):
– PFO in Cryptogenic Stroke Study (PICCS) substudy (Sunnichi Homma et at, 
Circulation 2002)
▪ DOAC versus Aspirin for Cryptogenic Stroke (ESUS)
– NAVIGATE-ESUS and RESPECT-ESUS failed to show benefit
– One size fits all strategy does not work and puts many in harms 
way with an increased and unnecessary bleeding risk
– Ongoing ARCADIA trial looking at ESUS + Left Atrial Cardiopathy
Shunichi H, Sacco R, et al. Effect of Medical Treatment in Stroke Patients With Patent
Foramen Ovale Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625-2631.
Atrial Fibrillation Basics
▪ 1. Abnormality of Rate
▪ 2. Irregular Rhythm
▪ 3. Absence of P-waves
The Gold Standard
▪ 12-Lead EKG
https://www.researchgate.net/figure/Standard-12-lead-ECG-atrial-fibrillation_fig5_318357744
- 12-channel readout using 10 electrodes
- Best electrocardiac resolution
- Manual p-wave evaluation
- Manual rhythm evaluation
- …just not portable
Norman Jefferis Holter
▪ Born in 1914
▪ experimental physicist who also worked on A-bomb testing
▪ Developed the first wearable
ECG monitor which was 
released for commercial 
production in 1962
Holter’s Ambulatory ECG
▪ The first easily wearable 
and conveniently portable
ECG monitor!
Go about your life’s normal 
activities like work, sleep or
even go for a bike ride!
Modern Techniques for 
Arrhythmia Detection
1. Rate
Inappropriate Tachycardia
▪ 1. check your pulse manually
– inaccurate, user dependent, impractical for 
constant monitoring, can be useful for 
symptomatic events
▪ 2. wear a device that can do it for you
– Something comfortable, familiar, useful for other 
things and is low cost 
Wearable Heart Rate Monitors
Wearable Heart Rate Monitors
▪ HR tracker
– Resting HR
– Spikes in HR
– Fastest rates
– Duration of tachy
– Frequency of events
– Some can give alerts
– Is Not an EKG
– Cannot differentiate
Afib from SVT
Identifying a Tachyarrhythmia
▪ Get a 12-Lead EKG
– But what if its gone by the time you come in to 
see your doctor?
▪ Take your own, portable, EKG on demand
– Pairing tachycardia detection with an on-
demand personal EKG may increase the 
specificity of events and help differentiate Afib 
from SVT, sinus tachycardia, artifact etc.
Portable EKG
▪ 2 electrodes, 1-Channel FDA approved EKGs by creating 
two contact points across the heart from the limbs.
▪ Recordable and sharable with your physician
https://www.alivetec.com/products/alivecor-kardia-mobile-ecg-for-iphone-and-android-free-express-post
https://shop.ekohealth.com/products/duo-ecg-digital-stethoscope
EKG plus Stethoscope
Rx only
Optional physician review $Multifunctional device
Portable EKG
▪ #1. Patient with 
Cryptogenic stroke has 
neg MCOT, declines ICM, 
purchases portable EKG 
device…
▪ #2. Patient with 
cryptogenic stroke seen 2 
weeks ago in clinic from 
SAR, unable to get MCOT 
yet and declines ICM…
Modern Techniques for 
Arrhythmia Detection
2. Irregularly Irregular Rhythm
R-R interval Analysis
▪ Together with rate, this is the most common 
analytic technique for automated algorithm 
based Afib detection
Types of Wearable Cardiac 
Monitors
▪ Many types with advantages and disadvantages
Wearable Cardiac Monitors
The Evolution and Application of Cardiac Monitoring in Cryptogenic Stroke and TIA. 
Miller, D et al. Curr Treat Options Neurol. 2016 Apr;18(4):17. PMID: 26923607.
Modern Techniques for 
Arrhythmia Detection
3. Absence of the p-wave
P-Wave Analysis
▪ Together with rate and rhythm analysis, the 
inclusion of p-wave detection has advanced 
the specificity of some of the automated Afib
detection algorithms 
Wearable Cardiac Monitors
▪ #1 63yo patient with 
Amaurosis Fugax, Pulm HTN 
and OSA, neg IPD tele, 
normal LA size, d/c on 
MCOT on day #4/30 I get a 
phone call ….
▪ #2 82yo patient with 
recurrent embolic appearing 
cryptogenic strokes, severely 
dilated LA, frequent PACs on 
MCOT but no Afib….
Wearable Cardiac Monitors
▪ Pros
– Simpler, smaller designs, patch or wire-leads
– More waterproof than before
– Offer more data (AF duration, PACs and other arrhythmias etc)
– Real-time telemetry reporting for some devices
– Non-invasive devices can monitor up to 30 days
– Insertable devices can monitor up to 3yrs
– Arrhythmia detection algorithms have advanced since earlier models
▪ Cons
– 12-Lead Holter monitors only 24-72hrs
– 14 day to 3yr monitoring devices reduced to only 1 or 2 channels
– Elderly often easily confused by the technology limiting usage
– The more complex the device, the more costly
– Detection dependent on algorithm, some proprietary, some better than 
others, not all use p-wave data
Flow of Wearable Monitor Utilization 
▪ screening 
▪ HR Tracker
▪ symptom/screening 
triggered on 
demand EKG
▪ Short term monitors 
for event capture 
and screening
▪ 30 day monitors
▪ 3yr ICM
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